首页 › 基金 › Portolan Capital Management, LLC › CDNA
Portolan Capital Management, LLC 对 CDNA 的持仓历史
CAREDX INC · 医疗保健
Portolan Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 CDNA(CAREDX INC)420,215 股,市值约 US$27.3M,约占其申报组合的 1.14%,在其申报持仓中市值排名第 26 位。 Portolan Capital Management, LLC 最近 7 个申报季度中有 7 个季度披露了 CDNA 持仓,最早可追溯至 Q1 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Portolan Capital Management, LLC 对 CDNA 的持仓演变
Portolan Capital Management, LLC 于 Q1 2025 首次披露 CDNA 持仓:411,683 股(约 US$7.3M)。 该持仓在 Q3 2026 达到峰值 420,215 股,市值约 US$27.3M。 在 7 次申报中,Portolan Capital Management, LLC 3 次增持、3 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 420,215 股、市值约 US$27.3M,环比减持 -264,590 股。。 持仓曾出现大幅变动:Q2 2025 增持约 53% (随后一个季度股价下跌 26%)、Q1 2026 减持约 55% (随后一个季度股价上涨 64%)、Q2 2026 增持约 101% (随后一个季度股价上涨 128%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2025 | 411.68K | $7.31M | 新进 |
| Q2 2025 | 629.98K | $12.31M | 增持 |
| Q3 2025 | 933.53K | $13.57M | 增持 |
| Q4 2025 | 758.77K | $14.30M | 减持 |
| Q1 2026 | 340.35K | $5.91M | 减持 |
| Q2 2026 | 684.80K | $19.52M | 增持 |
| Q3 2026 | 420.21K | $27.31M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CDNA 与 13F 数据
CDNA(CAREDX INC)属于医疗保健行业。我们追踪的基金中还有 51 只申报持有 CDNA,申报仓位最大的包括:Blue Water Life Science Advisors, LP (US$113.1M), 方舟投资 (US$104.6M), Divisadero Street Capital Management, LP (US$92.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CDNA 的基金
- Blue Water Life Science Advisors, LP 1.74M 股 · $113.10M · Q3 2026
- 方舟投资 1.61M 股 · $104.59M · Q3 2026
- Divisadero Street Capital Management, LP 1.42M 股 · $92.31M · Q3 2026
- GAGNON SECURITIES LLC 1.07M 股 · $69.84M · Q3 2026
- ORBIMED ADVISORS LLC 934.80K 股 · $60.76M · Q3 2026
- Amova Asset Management Americas, Inc. 625.42K 股 · $40.63M · Q3 2026
- Ophir Asset Management Pty Ltd 582.41K 股 · $37.86M · Q3 2026
- Palo Alto Investors LP 424.60K 股 · $27.60M · Q3 2026
- Zweig-DiMenna Associates LLC 389.81K 股 · $25.34M · Q3 2026
- Gagnon Advisors, LLC 286.89K 股 · $18.65M · Q3 2026
更多关于 Portolan Capital Management, LLC
常见问题
How long has Portolan Capital Management, LLC held CDNA?
Portolan Capital Management, LLC has disclosed CDNA holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Portolan Capital Management, LLC's current position in CDNA?
As of Q3 2026, Portolan Capital Management, LLC holds 420.21K shares of CDNA (CAREDX INC), valued at $27.31M, representing 1.14% of its reported portfolio and ranking #26.
Has Portolan Capital Management, LLC been buying or selling CDNA?
In the latest 13F filing (Q3 2026), Portolan Capital Management, LLC reduced its position in CDNA. The position peaked in Q3 2026 at 420.21K shares.
Which other funds hold CDNA?
Other major institutional holders of CDNA include Blue Water Life Science Advisors, LP, 方舟投资, Divisadero Street Capital Management, LP, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.